<http://webisa.webdatacommons.org/101910834>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<pagepress.org> .
<http://webisa.webdatacommons.org/101910834>	<http://www.w3.org/ns/prov#value>	"However, relapses remain frequent, especially in the absence of chronic-graft versus host disease.26 Therefore, post-transplant immunotherapy with donor-lymphocyte infusions and/or novel agents has been tested with the objective of upgrading the level of response." .
<http://webisa.webdatacommons.org/prov/435605686>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/101910834> .
<http://webisa.webdatacommons.org/101910834>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .